The Business Times

Companies & Markets

The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

SUBSCRIBERS

CVC, Temasek 'exploring options' for Alvogen

Published Tue, Sep 26, 2017 · 09:50 PM
Share this article.

Hong Kong

ALVOGEN'S owners - including CVC Capital Partners and Temasek Holdings - are said to be exploring options for the generic pharmaceutical company, which could be valued at about US$4 billion, according to people familiar with the matter.

The controlling shareholders of the drugmaker have held on-and-off talks with Shanghai Pharmaceuticals Holding Co focusing on a sale of Alvogen's US business, the people said. Alvogen would keep its operations in Asia as well…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here